Nek2 and other mitotic kinases are downstream of the E2F activators, and may modulate the epithelial-to-mesenchymal transition in breast cancer

被引：0
|
作者：
Rivera-Rivera, Yainyrette [1 ]
Marina, Mihaela [2 ]
Saavedra, Harold I. [1 ]
机构：
[1] Ponce Hlth Sci Univ, Ponce, PR USA
[2] Meditech Media, Atlanta, GA USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-2545
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2545
引用
收藏
页数：2
相关论文
共 50 条
  • [31] E2F8 regulates the proliferation and invasion through epithelial-mesenchymal transition in cervical cancer
    Kim, Lee Kyung
    Park, Sun-Ae
    Eoh, Kyung Jin
    Heo, Tae-Hwe
    Kim, Young Tae
    Kim, Hee Jung
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2020, 16 (02): : 320 - 329
  • [32] Epithelial-to-mesenchymal Transition Heterogeneity of Circulating Tumor Cells and Their Correlation With MDSCs and Tregs in HER2-negative Metastatic Breast Cancer Patients
    Papadaki, Maria A.
    Aggouraki, Despoina
    Vetsika, Eleni-Kyriaki
    Xenidis, Nikolaos
    Kallergi, Galaktea
    Kotsakis, Athanasios
    Georgoulias, Vassilis
    ANTICANCER RESEARCH, 2021, 41 (02) : 661 - 670
  • [33] Estrone, the major postmenopausal estrogen, binds ERa to induce SNAI2, epithelial-to-mesenchymal transition, and ER plus breast cancer metastasis
    Qureshi, Rehana
    Picon-Ruiz, Manuel
    Sho, Maiko
    Van Booven, Derek
    de Paiva, Vanessa Nunes
    Diaz-Ruano, Anna B.
    Ince, Tan A.
    Slingerland, Joyce
    CELL REPORTS, 2022, 41 (07):
  • [34] Hypoxic microenvironment promotes resistance to targeted therapies in HER2-overexpressing breast cancer involving epithelial-to-mesenchymal transition features.
    Judith Wolos, Virginia
    Jaqueline Tapia, Ivana
    Abrigo, Marianela
    Lacunza, Ezequiel
    de Kier Joffe, Elisa Dora Bal
    Leon Fiszman, Gabriel
    CANCER RESEARCH, 2021, 81 (13)
  • [35] Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition
    Lv, Zhi-Dong
    Kong, Bin
    Li, Jian-Guo
    Qu, Hui-Li
    Wang, Xin-Gang
    Cao, Wei-Hong
    Liu, Xiao-Yi
    Wang, Yu
    Yang, Zhao-Chuan
    Xu, Hui-Mian
    Wang, Hai-Bo
    ONCOLOGY REPORTS, 2013, 29 (01) : 219 - 225
  • [36] DACT2 silencing by promoter CpG methylation disrupts its regulation of epithelial-to-mesenchymal transition and cytoskeleton reorganization in breast cancer cells
    Xiang, Tingxiu
    Fan, Yichao
    Li, Chunhong
    Li, Lili
    Ying, Ying
    Mu, Junhao
    Peng, Weiyan
    Feng, Yixiao
    Oberst, Michael
    Kelly, Kathleen
    Ren, Guosheng
    Tao, Qian
    ONCOTARGET, 2016, 7 (43) : 70924 - 70935
  • [37] A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer
    Sjoberg, Elin
    Meyrath, Max
    Milde, Laura
    Herrera, Mercedes
    Lovrot, John
    Hagerstrand, Daniel
    Frings, Oliver
    Bartish, Margarita
    Rolny, Charlotte
    Sonnhammer, Erik
    Andy, Chevign E.
    Augsten, Martin
    Ostman, Arne
    CLINICAL CANCER RESEARCH, 2019, 25 (12) : 3702 - 3717
  • [38] Upregulated SCUBE2 expression in breast cancer stem cells enhances triple negative breast cancer aggression through modulation of notch signaling and epithelial-to-mesenchymal transition
    Chen, Jia-Hong
    Kuo, Kuang-Tai
    Bamodu, Oluwaseun Adebayo
    Lin, Yuh-Charn
    Yang, Ruey-Bing
    Yeh, Chi-Tai
    Chao, Tsu-Yi
    EXPERIMENTAL CELL RESEARCH, 2018, 370 (02) : 444 - 453
  • [39] NR2F2 plays a major role in insulin-induced epithelial-mesenchymal transition in breast cancer cells
    Xia, Baili
    Hou, Lijun
    Kang, Huan
    Chang, Wenhui
    Liu, Yi
    Zhang, Yanli
    Ding, Yi
    BMC CANCER, 2020, 20 (01)
  • [40] NR2F2 plays a major role in insulin-induced epithelial-mesenchymal transition in breast cancer cells
    Baili Xia
    Lijun Hou
    Huan Kang
    Wenhui Chang
    Yi Liu
    Yanli Zhang
    Yi Ding
    BMC Cancer, 20
12345